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Abstract 
Effectiveness of mass cholera vaccination campaigns requires not only technical and financial 
capacity but also consideration of social and cultural factors affecting vaccine acceptance. 
This study examined the influence of local community views of cholera on oral cholera 
vaccine (OCV) uptake in a mass vaccination campaign in 2009 in peri-urban and rural areas 
of Zanzibar. It used data from interviews conducted before the campaign and followed 
previous research assessing determinants of anticipated OCV acceptance. OCV uptake was 
lower than the reported anticipated acceptance. Less than half of the 356 adult respondents 
(49.7%) drank the required two doses of OCV. Variables referring to socio-cultural features 
of diarrheal illness that respondents identified with a cholera case vignette explained uptake 
better than analysis only of socio-demographic characteristics. Somatic features of illness not 
specific for cholera were negative determinants. Recognition of unconsciousness as a serious 
sign of dehydration and concern that cholera outbreaks would overwhelm the local healthcare 
system in the rural area were positive determinants of acceptance. Female gender, rural 
residence and older age were also positive determinants of OCV uptake. For further vaccine 
action with OCVs, cholera as a cause of severe dehydration should be distinguished from 
other causes of diarrhea. Planning should acknowledge rural concern about the relationship of 
limited capacity of the healthcare system to cope with cholera outbreaks and the priority of a 
cholera vaccine. Findings recommend particular efforts to increase cholera immunization 
coverage among young adults, in peri-urban areas and for men.  
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Introduction 
In 2009, 45 countries mainly from Africa and Asia reported a global total of 221,226 cases 
and 4,946 deaths attributable to cholera.1 Recognizing difficulties with limited surveillance 
and under-reporting, the World Health Organization (WHO) estimates annual morbidity and 
mortality to be in excess of 3 million cases and 100,000 deaths.2  
 
Besides timely rehydration and administration of antibiotics to patients who suffer from acute 
watery diarrhea caused by Vibrio cholerae O1 or O139, cholera control also involves 
preventive activities that center on the provision of safe water in sufficient quantities, 
sanitation and health education (WASH). Using oral cholera vaccines (OCV) has also been 
recommended to supplement WASH in an integrated strategy to reduce the public health 
burden of cholera in affected countries.3 In endemic settings, community-based mass 
vaccination campaigns in selected high-risk areas have been the preferred route for efficient 
deployment of OCV.  
 
Following research examining key epidemiological parameters and characteristics of available 
OCVs in different populations and contexts,4-7 studies have investigated the practical 
feasibility and economic aspects of using OCVs in vulnerable populations that are at risk of 
recurrent cholera outbreaks.8-13 Effective use of OCVs for maximum impact on morbidity and 
mortality depends on a variety of factors: in addition to the availability of a safe and 
efficacious vaccine and a well-functioning health system with sufficient capacity to 
implement mass immunizations, local views of potential respondents about cholera, and how 
these affect whether or not they would accept a vaccine, have to be considered for maximum 
coverage, but have often been neglected.14  
 
Recently published studies addressing the relationship between local perceptions of severe 
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enteric diarrheal illness and willingness or desire to receive vaccines have mainly focused on 
shigellosis and typhoid fever.15-21 Studies on cholera have assessed social factors of vaccine 
acceptance22 or have considered policymakers’ views,23 but empirical study of cultural factors 
of cholera and how they affect OCV uptake is lacking. 
 
Research reported in this paper took advantage of a mass vaccination campaign that was 
conducted in cholera-endemic areas of peri-urban and rural Zanzibar in 2009. Approximately 
50,000 inhabitants were targeted for vaccination with Dukoral®, which was the only OCV 
pre-qualified by the WHO at that time. This two-dose vaccine was offered without charge in 
two rounds in January and February 2009.24 Nine temporary vaccination posts were set up on 
each island in the target communities; posts were open daily for at least eight hours and 
staffed with local health personnel and villagers. 
 
A baseline survey, which was conducted six months before the mass vaccination campaign, 
examined social and cultural determinants of anticipated OCV acceptance.25 Findings from 
that study showed that 93.5% of the interviewed adults intended to take a vaccine if offered 
without charge. However, when offered at three different prices levels—approximately USD 
0.9, USD 4.5 and USD 9—acceptance rates dropped to 60.7%, 19.4% and 15.2%, 
respectively. Multivariable logistic regression models examining factors that affect vaccine 
acceptance if the OCV was offered at the three price levels showed that socio-cultural features 
of illness explain anticipated acceptance better than social epidemiological models containing 
mainly socio-demographic characteristics. 
 
Since intention to receive a vaccine does not always predict vaccination,26-28 examination of 
how cultural concepts of cholera determine actual OCV acceptance (or uptake) is much-
needed. Findings from such research may contribute essential information to increase 
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coverage of OCV in future mass vaccination campaigns for the benefit of cholera control in 
Zanzibar. 
 
This study used the integrated methods framework of cultural epidemiology.29 This research 
approach has been valuable in determining how local cultural concepts of illness (i.e., how 
people experience an illness, what causes they attribute it to and what they do for help 
seeking) affect health-related behavior.30-32 The aim of this work was to identify social and 
cultural determinants of OCV uptake based on a random sample of adults that was 
interviewed before the 2009 mass vaccination campaign in Zanzibar.33 
 
Methods 
Setting, study design and participants 
Zanzibar belongs to the United Republic of Tanzania and consists of two major islands, 
Unguja and Pemba, just off the coast between Dar-Es-Salaam in the south and the Kenyan 
border in the north. Zanzibar has been regularly affected by cholera since the 1970s, and the 
government therefore recently decided to vaccinate major hotspots on both islands with 
assistance from the WHO. The peri-urban community of Chumbuni on Unguja island and the 
rural community of Mwambe on Pemba island—representing two out of the six cholera-
endemic communities that had been identified as mass vaccination targets based on a review 
of recent epidemiological data—were chosen for this cross-sectional baseline survey. 
Chumbuni is located at the outskirts of the capital Stonetown on the west coast of Unguja. It 
belongs to the Urban district and was inhabited by approximately 11,000 people at the time of 
the study in 2008,33 relating to a population density of approximately 15,000/km2. Mwambe is 
located on the southeastern tip of Pemba and belongs to Mkoani district. Approximately 8,000 
people lived in 2008 in this rural village that is scattered in hamlets over a larger area than 
Chumbuni (population density: approximately 800/km2).   
 7 
 
Interviews were done by trained field workers between June and August 2008, roughly half a 
year before the campaign was conducted in January and February 2009. Following a simple 
random sampling procedure, 180 houses were drawn per site. This sample size, which was 
obtained after adding 10% for potentially missing data, was based on the requirements for a 
cross-sectional study to allow comparisons of key variables between both sites with 95% 
significance and 80% power.33 An equal number of men and women were approached at each 
village. The sampling frame came from existing geographic information system data (peri-
urban site) and from a local census (rural site). Adult community members were selected 
through the sampled houses and asked for an interview if they were diarrhea-free, aged 18 
years or older and fit for a discussion of about one hour duration. Three field teams per island, 
each comprising an interviewer and a note taker, completed on average two interviews per 
day. A more detailed description of both sites and more information on sampling has been 
presented elsewhere.33 
 
Instrument 
Semi-structured interviews based on the Explanatory Model Interview Catalogue (EMIC) are 
the principal instrument of inquiry in cultural epidemiological research.34 EMIC interviews 
allow empirical clarification of how locally valid features of illness-related experience, 
meaning and behavior are distributed in a population.35-37 Since adults who were apparently 
unaffected by cholera were the focus of this study, the EMIC interview began with the 
presentation of a clinical vignette that described a local person with cardinal somatic 
symptoms of cholera.33 The interview also recorded socio-demographic characteristics and 
asked about anticipated acceptance of the OCV if it was offered without charge and at three 
different levels of cost.  
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Approach to analysis 
Explanatory variables for analysis of determinants of OCV uptake were obtained from the 
baseline study.33 These included socio-demographic characteristics and socio-cultural features 
of cholera-like illness, operationalized as patterns of distress referring to categories of somatic 
symptoms and social, emotional and financial impact, categories of perceived causes, self-
treatment at home and help seeking outside households of affected persons. The outcome 
variable, respondents’ vaccination status, was obtained from the mass vaccination database 
that had been compiled with the use of personal digital assistants by the International Vaccine 
Institute, Seoul.24 Receipt of two complete doses of OCV was coded with a value of 1 (viz., 
fully immunized) and receipt of one or zero doses with a value of 0 (not immunized).  
 
Determinants of uptake were identified in a staged process that involved uni- and 
multivariable logistic regressions in SAS 9.2 (SAS Institute, Cary, NC, USA). Crude analysis 
examined associations between OCV and explanatory variables that were reported by 5-95% 
of respondents. Only variables with p<0.2 were retained for multivariable analyses to 
calculate ‘focal’ models for each subset of categories of socio-cultural features of illness (i.e., 
somatic symptoms, social impact, perceived causes and self-treatment at home). All focal 
models were adjusted for socio-demographic characteristics (e.g., gender, site, age, marital 
status etc.); the latter were also examined in a separate focal model. All variables identified in 
focal models with p<0.2 were then used for calculating a ‘comprehensive’ model of social 
and cultural determinants of OCV uptake. Assessment of which focal model explained 
vaccine uptake better than the focal model containing only socio-demographic characteristics 
was based on the Akaike Information Criterion, corrected for sample size (AICc). The 
difference (∆) of AICc between each model and the model with the lowest AICc was 
calculated; any focal model having a ∆(AICc) noticeably lower than the model only 
containing socio-demographic characteristics was considered better. Interaction of rural or 
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peri-urban site with each variable was tested individually in focal models; interaction terms 
were only retained if their p values were below 0.1. Only interaction terms present in the focal 
models were assessed for inclusion in the comprehensive model based on the same threshold 
of p<0.1. This approach to analysis followed exactly the one laid out in the study of 
anticipated OCV acceptance to ensure full technical comparability.25 
 
Anticipated acceptance if the OCV was offered without charge, and at low, medium and high 
price, respectively, were also considered as potential explanatory variables; however, only 
anticipated acceptance of a free OCV was included in an additional focal model because 
crude analysis showed no associations between intention to buy an OCV and uptake in the 
campaign (p>0.2). Because 15.5% of the sample had reported a personal or household episode 
of cholera,25 previous illness experience was also considered as potential explanatory variable, 
but not included in further analyses since crude analysis showed no suggestive association 
(p=0.44). 
 
This study was approved by the Research Ethics Review Committee of the World Health 
Organization and the Ethics Committee of the Ministry of Health of Zanzibar. All study 
participants gave written consent before being interviewed. 
 
Results 
Sample characteristics 
A total of 356 interviews were completed, 179 in the peri-urban and 177 in the rural site. 
Slightly more than half of the study participants were women (50.3%). Mean age was 35.5 
years, 76.4% were married and the mean household size was 6.8 persons. Major occupations 
were farming (30.6%), being housewife (21.4%) and working in the informal economy 
(17.1%). The sample consisted of Muslims, with the exception of one Christian woman. A 
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majority (55.9%) reported a regular and dependable household income. Further details of 
sample characteristics have been described elsewhere.33 
 
OCV uptake 
Less than half of the respondents (49.7%) actually drank two doses of OCV, as documented 
in the mass vaccination database. More rural than peri-urban respondents drank the vaccine 
(58.8% vs. 40.8%, p<0.01, Chi2 test); and more women than men (54.8% vs. 44.6%), though 
with borderline statistical significance (p=0.056, Chi2 test). 
 
Social and cultural determinants of OCV uptake 
Crude analysis and focal models 
Table 1 presents all variables that were identified in crude analysis together with focal models 
of socio-cultural features of illness (i.e., patterns of distress, perceived causes and self-
treatment at home), of intention to receive the free OCV and of socio-demographic 
characteristics.  
 
According to their ∆(AICc) values, focal models of somatic symptoms and social impact and 
the model containing the ‘intention to receive the free OCV’ variable explained uptake better 
than the model containing only socio-demographic characteristics. Respondents who 
identified unconsciousness as a priority symptom and those among the rural respondents who 
strongly believed that cholera patients may cause a disruption in the local healthcare services 
were more likely to drink the OCV. Rural respondents and older respondents were also more 
likely to become vaccinated; and women tended to accept it more than men, though with 
borderline significance (p=0.053). Nausea was the only negative determinant of OCV uptake 
identified in any focal model. 
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Comprehensive model 
All socio-cultural features of illness identified as significant determinants of OCV uptake in 
the focal models (Table 1) were retained with similar effects in the comprehensive model that 
includes interactions with site (Table 2). An additional somatic symptom, loss of appetite, 
showed a negative association, but only in the rural site. Socio-demographic characteristics 
were also the same as in the focal model, with female gender clearly a significant positive 
determinant of OCV uptake (p=0.03). Anticipated acceptance for a free OCV appears to 
influence uptake; the adjusted regression coefficient is 0.91, but only marginally significant 
(p=0.078). 
 
The overall effect of site (adjusted regression coefficient: 0.94, 95% confidence interval: 0.47 
to 1.42, p<0.01) showed that rural respondents were more likely to accept the OCV (main 
effects model, not shown). 
 
Comparing social and cultural determinants of anticipated acceptance and uptake of a 
free OCV 
Because anticipated acceptance of a free OCV was almost 95%, a multivariable logistic 
regression of determinants of this outcome would be inappropriate. Nevertheless, to address 
the question of whether determinants of anticipated acceptance and of actual acceptance (i.e., 
uptake) are similar or different, univariable logistic regression was conducted to compare 
results for each outcome. Table 3 shows the variables that were associated in crude analysis 
(p<0.05) with respondents’ willingness to receive a free OCV, including borderline results for 
gender and site. Similar to the crude analysis of uptake (Table 1), categories related to social 
impact, perceived causes, self-treatment at home and socio-demographic variables were 
identified as significant determinants.  
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Respondents who reported that cholera outbreaks may disrupt healthcare services were more 
likely both to have anticipated acceptance of the vaccine and to have actually taken it. Fear of 
infecting others, another cholera-related social concern, was also positively associated with 
anticipated acceptance but not uptake. Among perceived causes, only supernatural factors 
were identified as determinants of anticipated acceptance and uptake: respondents reporting 
God’s will as a cause of cholera were less likely to anticipate vaccine acceptance, but 
respondents identifying witchcraft were more likely to actually drink the vaccine. Even 
though respondents who reported drinking more water or other liquids as a means of 
rehydration at home were more likely to anticipate acceptance, they were less likely to take 
the vaccine during the campaign.  
 
Among socio-demographics, only two characteristics were identified as determinants in both 
analyses: gender and site. Although with borderline significance, women were more willing to 
accept the vaccine (p=0.056) and actually also drank it more often than men (p=0.057); 
residing at the rural site was a borderline negative determinant for anticipated acceptance 
(p=0.056), but a highly significant positive determinant for uptake (p<0.01). Reporting a 
regular and dependable household income was a positive determinant of anticipated vaccine 
acceptance, but this variable did not determine vaccine uptake. Increasing age, being married 
and being a farmer/fisherman were only positively associated with vaccine uptake.  
 
Discussion 
To improve the use of vaccines in endemic communities, public health planners need not only 
know coverage rates of vaccination campaigns, but also what social and cultural factors may 
have contributed to the achieved coverage.38 By empirically examining the relationship 
between cultural concepts of illness and OCV uptake, a connection which has rarely been 
considered by classical epidemiologists and public health officials,39 this study developed an 
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approach for contributing relevant information to help local decision makers to improve 
cholera control. 
 
Pre-vaccination study results showed a high rate of anticipated acceptance (94%) across both 
islands. Despite this and the local organization and implementation of the 2009 mass 
vaccination campaign that attempted to minimize other access-related issues, uptake of the 
OCV was notably lower (50%). This uptake rate was between rates of two recent mass 
vaccination campaigns conducted in Africa and Asia. The 2003/2004 campaign using 
Dukoral® in an urban endemic neighborhood in the coastal town of Beira, Mozambique, 
estimated coverage of approximately 41% for people 15 years and older.8 Coverage with a 
locally produced two-dose OCV in a campaign conducted in 1998 in 13 communes of coastal 
Hue City, Vietnam, amounted to 74% for people aged 20 and above, and with significantly 
higher coverage among women.13 
 
Socio-cultural features of cholera-like illness determined vaccine uptake better than if only 
social epidemiological factors were considered; this confirms the finding from the pre-
vaccination survey and indicates the use of social and cultural study to examine anticipated 
and actual vaccine acceptance. 
 
Demotivating factors for OCV uptake were related to symptoms of malaise: priority for 
getting a vaccine was reduced when people associated cholera with nausea and loss of 
appetite, which are not cholera-specific symptoms.  
 
Higher OCV uptake in the rural site was further reinforced by the fact that concern about the 
detrimental impact of cholera outbreaks on local healthcare services was a positive 
determinant of uptake among rural respondents only. Rural villagers feared that the local 
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healthcare system would be overburdened with cholera cases; this might explain their 
preference for vaccination, although supplementary WASH activities were also frequently 
demanded.25 This finding and the previously reported higher rural than peri-urban willingness 
to buy the OCV at a price of almost USD 1025 suggest a higher priority for using OCV in 
rural Zanzibar.  
 
Perceived severity of illness may influence desire for enteric vaccines.15-17 Because cholera 
was almost universally reported in both communities as “very serious” (97%) and “usually or 
sometimes fatal without treatment” (96%) (not shown), the influence of illness-related 
severity and fatality could not directly be analyzed as potential determinants of OCV uptake. 
Perceptions regarding severity and potential fatality were nevertheless related to vaccine 
acceptance in these communities because unconsciousness, a feature of dehydration and thus 
an advanced stage of cholera, was not only reported as one of the most prominent somatic 
problems,33 but it was also identified as positive determinant of OCV uptake. 
 
Increasing age and female gender were further positive determinants of OCV uptake. In 
contrast, Ali et al., who studied how socio-demographic and spatial variables influenced 
participation in a cholera vaccination trial in Kolkata, India, found that younger age was 
positively related.22 Although previous personal or household illness experience was not 
associated with OCV uptake, older people might have drunk the vaccine more often because 
of their higher likelihood to have witnessed the grave consequences of cholera. In line with 
the Kolkata study22 and the 1998 mass vaccination campaign in Vietnam,13 men were less 
likely to accept oral cholera vaccination. As in Zanzibar, it is not clear whether this reflects 
more responsibility or self-perceived vulnerability among women. 
 
In addition to focusing on socio-cultural features of cholera, anticipated acceptance of the free 
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OCV was also assessed and found to be a tentative positive predictor of uptake. However, 
evidence that intention to receive a vaccine is directly related to vaccination behavior is still 
inconclusive;27,28,40 because of this and because no studies have yet firmly established such an 
association for cholera, further research is warranted to investigate this relationship. 
 
Social and cultural determinants of anticipated acceptance and uptake of an OCV in a mass 
vaccination campaign in Zanzibar were not directly comparable because of almost universal 
willingness to accept free immunization. Recognizing this statistical limitation, comparison of 
crude associations nevertheless showed that categories related to social impact, perceived 
causes, self-treatment at home and socio-demographics are relevant determinants for both 
anticipated vaccine acceptance and actual behavior. 
 
Although findings from this study were not available to guide planning for the campaign in 
Zanzibar, they may be relevant to guide future cholera mass vaccination action in the area. 
This study focused on adults in a cholera-endemic setting, but findings also indicate potential 
for such research in settings of epidemic cholera and to address the priorities of children. 
 
Conclusion 
Uptake of a free OCV in the 2009 mass vaccination campaign in a peri-urban and a rural 
endemic area of Zanzibar was lower than anticipated acceptance. This study showed that 
consideration of socio-demographic and economic factors is necessary but not sufficient to 
explain coverage, because socio-cultural features of cholera-like illness determined vaccine 
uptake better than purely social epidemiological models.  
 
Social mobilization in future vaccination campaigns in Zanzibar to achieve the goal of 
elimination should benefit from findings presented here. Cholera as a cause of severe 
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dehydration should be emphasized vis-à-vis its moderate malaise-related symptoms. Rural 
recognition of the cholera-related burden on the local healthcare system was reflected by a 
priority for oral cholera vaccination; this shows not only the importance of vaccination for 
cholera control but also the need to strengthen healthcare services in Zanzibar, particularly in 
rural areas. Inasmuch as resources for public health are generally scarce in Zanzibar, findings 
indicate the importance to sensitize young adults, residents of peri-urban areas, and men to the 
value of the oral cholera vaccine for preventing cholera.  
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Tables 
Table 1 Crude analysis and focal models of social and cultural determinants of oral cholera 
vaccine uptake in a community mass vaccination campaign in Zanzibar, 2009, n=356 
 Crude analysisa  Focal modelsb   
 Coeff.c 95% CId p valuee  Coeff.c 95% CId p valuee Intf ∆(AICc)g 
Categories of distress: somatic symptoms           0 
Loss of appetite -0.34 -0.70 0.02 0.07        
Loss of appetite (peri-urban site)      0.15 -0.33 0.62 0.54   
Loss of appetite (rural site)      -0.58 -1.22 0.06 0.08 *  
Nausea -0.49 -0.99 0.02 0.06  -0.65 -1.22 -0.08 0.03   
Palpitations -0.19 -0.44 0.06 0.14  -0.03 -0.31 0.24 0.81   
Unconsciousness 0.11 -0.05 0.27 0.18  0.21 0.04 0.38 0.02   
Categories of distress: social impact           3.06 
Fear of isolation from others -0.11 -0.27 0.05 0.18  -0.12 -0.29 0.05 0.16   
Disruption of healthcare services 0.36 0.01 0.70 0.04        
Disruption of healthcare services 
(peri-urban site)     
 -0.07 -0.53 0.38 0.75   
Disruption of healthcare services 
(rural site)     
 1.01 0.15 1.87 0.02 **  
Perceived causes           10.77 
Unprotected/spoiled food -0.15 -0.38 0.07 0.18  -0.02 -0.26 0.22 0.86   
Contact with contaminated water 0.19 -0.03 0.41 0.08  0.13 -0.11 0.37 0.28   
Witchcraft 0.50 0.08 0.91 0.02  0.26 -0.18 0.69 0.25   
Cannot say 0.35 -0.07 0.77 0.10  0.21 -0.24 0.66 0.36   
Self-treatment at home           5.83 
Drinking more water or liquids -0.16 -0.30 -0.01 0.04  -0.12 -0.28 0.03 0.12   
Intention to receive OCV           4.44 
Anticipated acceptance of a free OCV 0.87 -0.05 1.78 0.06  0.91 -0.06 1.87 0.07   
Socio-demographic characteristicsh           6.05 
Gender (male vs. female) -0.41 -0.82 0.01 0.06  -0.48 -0.97 0.01 0.05   
Site (rural vs. peri-urban) 0.73 0.31 1.15 <0.01  0.73 0.15 1.31 0.01   
Age 0.02 0.00 0.03 0.01  0.02 0.01 0.04 0.01   
Marital status (married vs. not married) 0.68 0.18 1.19 <0.01  0.31 -0.25 0.88 0.27   
Main occupation (housewife/student/retired 
vs. farmer/fisherman) -0.58 -1.07 -0.09 0.02
i  -0.02 -0.70 0.66 0.96   
Main occupation (informal business/formally 
employed vs. farmer/fisherman) -0.56 -1.09 -0.03 0.04
i 
  
-0.04 -0.70 0.61 0.90   
 
aOnly variables with univariable association at p<0.2 listed;  
bEach model adjusted for socio-demographic characteristics, see footnote h;  
cLogistic regression coefficient;  
d95% Confidence interval;  
eFigures in bold if p<0.05;  
fInteraction of rural with peri-urban site (baseline) considered if p value of interaction term 
less than 0.1 (* p<0.1, ** p<0.05);  
gDifference of corrected Akaike Information Criterion (AICc) between each model and the 
‘best’ model, designated with ∆(AICc)=0. Bold figures indicate models that explain vaccine 
acceptance better than the socio-demographic model only;  
hVariables used for adjusting. Figures reported in adjusted analysis refer to model with socio-
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demographic characteristics alone;  
iVariable is nominal with 3 categories, overall p=0.04
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Table 2 Comprehensive model of social and cultural determinants of oral cholera vaccine 
uptake in a community mass vaccination campaign in Zanzibar, 2009, n=356 
 Comprehensive modela  
  Coeff.b 95% CIc p valued Inte 
Categories of distress: somatic symptoms      
Loss of appetite (peri-urban site) 0.12 -0.36 0.59 0.63  
Loss of appetite (rural site) -0.67 -1.34 -0.00 0.05 * 
Nausea -0.64 -1.21 -0.08 0.03  
Unconsciousness 0.19 0.02 0.37 0.03  
Categories of distress: social impact      
Fear of isolation from others -0.08 -0.26 0.09 0.35  
Disruption of healthcare services (peri-urban site) -0.06 -0.52 0.39 0.79  
Disruption of healthcare services (rural site) 0.91 0.00 1.81 0.05 * 
Self-treatment at home      
Drinking more water or liquids -0.13 -0.29 0.03 0.12  
Intention to receive OCV      
Anticipated acceptance of a free OCV 0.91 -0.10 1.92 0.08  
Socio-demographic characteristics      
Gender (male vs. female) -0.51 -0.97 -0.05 0.03  
Site (rural vs. peri-urban) 0.83 -0.41 2.07 0.19  
Age 0.03 0.01 0.04 <0.01  
 
aOnly variables identified in focal models at p<0.2 included in comprehensive adjusted 
model;  
bLogistic regression coefficient;  
c95% Confidence interval;  
dFigures in bold if p<0.05;  
eInteraction of rural with peri-urban site (baseline) considered if p value of interaction term 
less than 0.1 (* p<0.1)  
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Table 3 Crude analysis of social and cultural determinants of anticipated acceptance of a free 
oral cholera vaccine in Zanzibar, n=356 
  Crude analysisa 
  Coeff.b 95% CIc p value 
Categories of distress: social impact     
Fear of infecting others 0.86 0.19 1.54 0.01 
Disruption of healthcare services 0.89 0.06 1.72 0.04 
Perceived causes     
God's will -0.37 -0.64 -0.10 <0.01 
Self-treatment at home     
Drinking more water or liquids 0.55 0.05 1.04 0.03 
Socio-demographic characteristics     
Gender (male vs. female) -0.89 -1.81 0.02 0.06 
Site (rural vs. peri-urban) -0.89 -1.81 0.02 0.06 
Regular and dependable household income 1.14 0.22 2.05 0.02 
 
aOnly variables listed with univariable association with anticipated acceptance of a free OCV 
at p<0.05, except gender and site;  
bLogistic regression coefficient;  
c95% Confidence interval 
 
